166 related articles for article (PubMed ID: 29599181)
1. Proton pump inhibitor therapy after
Tan MC; Graham DY
BMJ Evid Based Med; 2018 Jun; 23(3):111-112. PubMed ID: 29599181
[No Abstract] [Full Text] [Related]
2. Long-term proton pump inhibitor use after
Kobayashi J; Uchida H; Ito J
Gut; 2019 Jun; 68(6):1131. PubMed ID: 29802173
[No Abstract] [Full Text] [Related]
3.
Suzuki H; Matsuzaki J
Gut; 2018 Nov; 67(11):2071-2072. PubMed ID: 29247066
[No Abstract] [Full Text] [Related]
4. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
[No Abstract] [Full Text] [Related]
5. Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.
Matsukura N; Tajiri T; Kato S; Togashi A; Masuda G; Fujita I; Tokunaga A; Yamada N
Gastric Cancer; 2003; 6(2):100-7. PubMed ID: 12861401
[TBL] [Abstract][Full Text] [Related]
6. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Holtmann G; Layer P; Goebell H
Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
[TBL] [Abstract][Full Text] [Related]
7. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
Vakil N
Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
[TBL] [Abstract][Full Text] [Related]
8. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
Buzás GM; Józan J
Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
Kuipers EJ
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
[TBL] [Abstract][Full Text] [Related]
11. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
[TBL] [Abstract][Full Text] [Related]
12. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
Hwang JJ; Lee DH; Kang KK; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(13):3936-43. PubMed ID: 25852279
[TBL] [Abstract][Full Text] [Related]
13. Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy.
Hirasaki S; Matsubara M; Ikeda F; Taniguchi H; Suzuki S
Intern Med; 2007; 46(12):855-8. PubMed ID: 17575378
[TBL] [Abstract][Full Text] [Related]
14. Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial.
Kim CG; Song HJ; Kook MC; Hong EK; Park S; Lee JY; Lee JH; Ryu KW; Kim YW; Bae JM; Choi IJ
Am J Gastroenterol; 2008 Jan; 103(1):48-54. PubMed ID: 17714557
[TBL] [Abstract][Full Text] [Related]
15. Rabeprazole: the role of proton pump inhibitors in Helicobacter pylori eradication.
Sharara AI
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):863-70. PubMed ID: 16307499
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
[TBL] [Abstract][Full Text] [Related]
17. [Helicobacter pylori eradication therapy in Korea].
Kim SY; Jung SW
Korean J Gastroenterol; 2011 Dec; 58(2):67-73. PubMed ID: 21873820
[TBL] [Abstract][Full Text] [Related]
18. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
[TBL] [Abstract][Full Text] [Related]
19. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
[TBL] [Abstract][Full Text] [Related]
20. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study.
Higuchi K; Fujiwara Y; Tominaga K; Watanabe T; Shiba M; Nakamura S; Oshitani N; Matsumoto T; Arakawa T
Aliment Pharmacol Ther; 2003 Jan; 17(1):111-7. PubMed ID: 12492739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
